Interaction Between NGF and Acute Exercise-induced Ischemia
NCT03470038 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2019-02-15
Summary
The purpose of this study is to investigate pain evoked responses and facilitation of NGF-induced mechanical muscle hyperalgesia over time following an acute exercised-induced ischemic condition in a NGF-sensitized muscle.
Conditions
- Hyperalgesia
- Pain Response
- Healthy Subjects
Interventions
- DRUG
-
NGF
Intramuscular injection
- DRUG
-
Isotonic saline
Intramuscular injection
Sponsors & Collaborators
-
Aalborg University
lead OTHER
Principal Investigators
-
Line Bay Sørensen, Ph.d stud. · Aalborg University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-03-15
- Primary Completion
- 2018-05-15
- Completion
- 2018-06-15
Countries
- Denmark
Study Locations
More Related Trials
-
Data Collection of Standard Care of Patients in the EMG Section
NCT05041387 ·Status: RECRUITING
-
Impact of Peripheral Afferent Input on Central Neuropathic Pain
NCT05646810 ·Status: UNKNOWN ·Phase: NA
-
Efficacy Study of Botox to Treat Neuropathic Pain
NCT00527202 ·Status: COMPLETED ·Phase: PHASE4
-
A Microneurography Study of NaV1.8 Inhibition in Healthy Adults
NCT06420765 ·Status: COMPLETED ·Phase: PHASE1
-
The Significance of Peripheral Input
NCT04764045 ·Status: UNKNOWN ·Phase: NA
-
Excitability Protocol: Voltage-gated Ion Channels
NCT05368532 ·Status: UNKNOWN ·Phase: NA
-
Capsaicin-induced Muscle Pain in Humans
NCT02377180 ·Status: COMPLETED ·Phase: NA
-
Analysis of Cortical Excitability in Neuropathic Pain
NCT00789347 ·Status: UNKNOWN
-
Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy
NCT00381719 ·Status: COMPLETED ·Phase: PHASE2
-
Pain-related Evoked Potentials in Unilateral Peripheral Nerve Injuries
NCT03082820 ·Status: COMPLETED
-
Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain
NCT04737278 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Trial to Evaluate Safety, Tolerability and Efficacy of NFX88 in SCI
NCT04148573 ·Status: COMPLETED ·Phase: PHASE2
-
Probing the Role of Sodium Channels in Painful Neuropathies
NCT02243475 ·Status: UNKNOWN
-
Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain
NCT03341832 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Lidocaine: Predictors of Response in Peripheral Nerve Injury
NCT01112748 ·Status: COMPLETED ·Phase: PHASE4
-
Cortical Representation of Hyperalgesia Induced by Nerve Growth Factor
NCT02159170 ·Status: COMPLETED ·Phase: NA
-
Impact of Oral Magnesium on Neuropathic Pain
NCT01121653 ·Status: COMPLETED ·Phase: PHASE4
-
Adalimumab in Severe and Acute Sciatica
NCT00470509 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Capsaicin-induced Pain on Homeostatic Plasticity in Healthy Human Participants
NCT04485689 ·Status: UNKNOWN ·Phase: NA
-
Efficacy Study Comparing Compounded Topical Pain Creams vs. Placebo for Treating Pain Symptoms
NCT02497066 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study in Patients With Refractory Chronic Lower Limb Neuropathic Pain and/or Back Neuropathic Pain.
NCT04852107 ·Status: TERMINATED ·Phase: NA
-
Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment
NCT03348735 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain
NCT04082975 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain
NCT01207596 ·Status: COMPLETED ·Phase: PHASE4
-
Axon Therapy for Post-Traumatic Peripheral Neuropathic Pain Compared to Conventional Medical Management
NCT04795635 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA